U.S. Markets closed

Peregrine Pharmaceuticals, Inc. (PPHM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.15+0.03 (+0.96%)
At close: 4:00PM EDT
People also watch
GALECTICTHLDXOMACYTR
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue4/30/20174/30/20164/30/2015
Total Revenue57,63044,68626,781
Cost of Revenue38,25922,96615,593
Gross Profit19,37121,72011,188
Operating Expenses
Research Development28,29759,52942,996
Selling General and Administrative19,33418,55118,691
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-28,260-56,360-50,499
Income from Continuing Operations
Total Other Income/Expenses Net108722142
Earnings Before Interest and Taxes-28,152-55,638-50,357
Interest Expense7141
Income Before Tax-28,159-55,652-50,358
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-28,159-55,652-50,358
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-28,159-55,652-50,358
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-32,799-60,136-54,054